Nun Study

Last updated

The Nun Study of Aging and Alzheimer's Disease is a continuing longitudinal study, begun in 1986, to examine the onset of Alzheimer's disease. [1] [2] David Snowdon, an Epidemiologist and the founding Nun Study investigator, started the Nun Study at the University of Minnesota, later transferring the study to the University of Kentucky in 1990. [3] In 2008, with Snowdon's retirement, the study returned to the University of Minnesota. [4] The Nun Study was very briefly moved from the University of Minnesota to Northwestern University in 2021 under the directorship of Dr. Margaret Flanagan. [5] The Nun Study is currently housed at the University of Texas Health San Antonio in the Bigg's Institute for Alzheimer's and Neurodegenerative diseases under the continued directorship of Neuropathologist, Dr. Margaret Flanagan. [6] [7]

Contents

The Sisters' autobiographies written just before they took their vows (ages 19–21) revealed that positivity was closely related to longevity and idea density, which is related to conversation and writing. [1] [8] [9] [10] This research found that higher idea density scores correlated with a higher chance of having sufficient mental capacity in late-life, despite neurological evidence that showed the onset of Alzheimer's disease. [2] [9] [10]

In 1992, researchers at Rush University Medical Center Rush Alzheimer's Disease Center (RADC), building on the success of the Nun Study, proposed the Rush Religious Orders Study. The Religious Orders Study was funded by the National Institute on Aging in 1993, and was ongoing, as of 2012. [11]

Origin and procedure

The Nun Study began in 1986 with funding by the National Institute on Aging. This study was focused on a group of 678 American Roman Catholic Sisters who were members of the School Sisters of Notre Dame. The purpose of the study was to conclude if activities, academics, past experiences, and disposition are correlated to continued cognitive, neurological, and physical ability as individuals got older, as well as overall longevity. [12] [13] The Nun Study participants were gathered on a volunteer basis following a presentation on the importance of donating one's brain for research purposes after death. Prior to the study's beginning, researchers required the participants to be cognitively intact and at least 75 years of age and for the Sisters to participate in the study until time of death. Participation in the study included the following; all participants gave permission for researchers to have access to their autobiographies and personal documented information and to participate in regular physical and mental examinations. [13] These examinations were designed to test the subject's proficiency with object identification, memory, orientation, and language. These categories were tested through a series of mental state examinations with the data being recorded with each passing test. Nun Study participants were asked to give permission for their brains to be donated at time of death so that their brains could be neuropathologically evaluated for changes related to Alzheimer's disease and other dementias. [13] Neuropathology evaluations for the Nun Study were performed by creating microscope slides from brain autopsy samples. Microscope slides that were created from the Nun Study brain autopsy samples were carefully evaluated for changes of Alzheimer's disease by specialized Physicians called Neuropathologists. [14] [15]

All Nun Study participants willingly signed a form agreeing to the terms of the study. [1] As of 2017, there were three participants still living. Studying a relatively homogeneous group (no drug use, little or no alcohol, similar housing and reproductive histories) minimized the extraneous variables that may confound other similar research studies. [16]

During the examination process Snowdon was able to compare the collected cognitive test scores with the neuropathology data that was obtained from examining the brains of the subject and quantifying microscopic changes. [2] These results assisted in giving new layers of understanding to the nature of Alzheimer's disease and other dementias. He concluded that Alzheimer's disease is likely caused by early childhood experiences or trauma instead of something from adulthood. [2]

Results

Researchers accessed the convent archive to review documents amassed throughout the lives of the nuns in the study. They also collected data via annual cognitive and physical function examinations conducted throughout the remainder of the participants' lives. After the death of a participant, the researchers would evaluate the brains of the deceased to assess any brain pathology. [17] Neuropathology evaluations for the Nun Study were performed by creating microscope slides from brain autopsy samples. Microscope slides that were created from the Nun Study brain autopsy samples were carefully evaluated for changes of Alzheimer's disease by specialized Physicians called Neuropathologists. [18] The original Neuropathologist for the Nun Study was Dr. William Markesbery. [19] [20]

Writing, emotions, lifestyle and cognition

One of the major findings from the nun study was how the participants' lifestyle and education may deter Alzheimer's symptoms. Participants who had an education level of a bachelor's degree or higher were less likely to develop Alzheimer's later in life. They also lived longer than their colleagues who did not have higher education. [2] Furthermore, the participants' word choice and vocabulary were also correlated to the development of Alzheimer's. Among the documents reviewed were autobiographical essays that were written by the nuns upon joining the sisterhood. Upon review, it was found that an essay's lack of linguistic density (e.g., complexity, vivacity, fluency) functioned as a significant predictor of its author's risk for developing Alzheimer's disease in old age. However, the study also found that the Sisters who wrote positively in their personal journals were more likely to live longer than their counterparts. [21]

Snowdon and associates found three indicators of longer life when coding the sister's autobiographies: the number of positive sentences, positive words, and the variety of positive emotions used. [8] The less positivity in writing correlated with greater mortality. There were many variables this study was unable to glean from the autobiographies of the sisters, such as long term hopefulness or bleakness in one's personality, optimism, pessimism, ambition, and others. [8]

The average age of nuns who began an autobiography was 22 years. [8] Some participants who used more advanced words in their autobiography had less symptoms of Alzheimer's in older years. Roughly 80% of nuns whose writing was measured as lacking in linguistic density went on to develop Alzheimer's disease in old age; meanwhile, of those whose writing was not lacking, only 10% later developed the disease. [21] This was found when researchers examined neuropathology after nuns died, confirming that most of those who had a low idea density had Alzheimer's disease, and most of those with high idea density did not. [21]

Snowdon found that exercise was inversely correlated with development of Alzheimer's disease, showing that participants who engaged in some sort of daily exercise were more likely to retain cognitive abilities during aging. [22] Participants who started exercising later in life were more likely to retain cognitive abilities, even if not having exercised before. [23]

Neuropathology

In 1992, a gene called apolipoprotein E was established as a possible factor in Alzheimer's disease, [24] but its presence did not predict disease with certainty. [25] Existence of amyloid beta plaques and Tau neurofibrillary tangles in the brain are required for the diagnosis of Alzheimer's Disease Neuropathologic Change to me made. [26] [27] Results from the Nun Study indicated that Tau neurofibrillary tangles located in regions of the brain outside the neocortex and hippocampus may have less of an effect than amyloid beta plaques located within those same areas. Another important factor was brain weight, as subjects with brains weighing under 1000 grams were seen as higher risk than those in a higher weight class. [28]    

Conclusions and further research

Overall, findings of the Nun Study indicated multiple factors concerning expression of Alzheimer's traits. The data primarily stated that age and disease do not always guarantee impaired cognitive ability and "that traits in early, mid, and late life have strong relationships with the risk of Alzheimer's disease, as well as the mental and cognitive disabilities of old age." [29]

The findings influenced other scientific studies and discoveries, one of which indicated that if a person has a stroke, there is a smaller requirement of Alzheimer's brain lesions necessary to diagnose a person with dementia. [30] Another is that postmortem MRI scans of the hippocampus can help distinguish that some nondemented individuals fit the criteria for Alzheimer's disease. [31] Researchers have also used the autopsy data to determine that there is a relationship between the number of teeth an individual has at death with how likely they were to have had dementia. Those with fewer teeth were more likely to have dementia while living. [32] Another study reaffirmed the findings of The Nun Study that higher idea density is correlated with better cognition during aging, even if the individual had brain lesions resembling those of Alzheimer's disease. [9] A 2019 study combined The Nun Study and Max Weber's vocational lectures, indicating that the vocation and lifestyle of nuns correlated with higher potential for developing dementia. [33] [34] Using research from the original study, Weinstein et al. found a correlation between longevity, and autonomy. Subjects were shown to have a longer lifespan based on the amount of purposeful and reflective behavior shown in their writing. [35]

Related Research Articles

<span class="mw-page-title-main">Frontotemporal dementia</span> Types of dementia involving the frontal or temporal lobes

Frontotemporal dementia (FTD), or frontotemporal degeneration disease, or frontotemporal neurocognitive disorder, encompasses several types of dementia involving the progressive degeneration of frontal and temporal lobes. FTDs broadly present as behavioral or language disorders with gradual onsets. Common signs and symptoms include significant changes in social and personal behavior, apathy, blunting of emotions, and deficits in both expressive and receptive language. Currently, there is no cure for FTD, but there are treatments that help alleviate symptoms.

Aging of the brain is a process of transformation of the brain in older age, including changes all individuals experience and those of illness. Usually this refers to humans.

<span class="mw-page-title-main">Progressive supranuclear palsy</span> Medical condition

Progressive supranuclear palsy (PSP) is a late-onset neurodegenerative disease involving the gradual deterioration and death of specific volumes of the brain. The condition leads to symptoms including loss of balance, slowing of movement, difficulty moving the eyes, and cognitive impairment. PSP may be mistaken for other types of neurodegeneration such as Parkinson's disease, frontotemporal dementia and Alzheimer's disease. The cause of the condition is uncertain, but involves the accumulation of tau protein within the brain. Medications such as levodopa and amantadine may be useful in some cases.

<span class="mw-page-title-main">Neuropathology</span> Study of disease of nervous system tissue

Neuropathology is the study of disease of nervous system tissue, usually in the form of either small surgical biopsies or whole-body autopsies. Neuropathologists usually work in a department of anatomic pathology, but work closely with the clinical disciplines of neurology, and neurosurgery, which often depend on neuropathology for a diagnosis. Neuropathology also relates to forensic pathology because brain disease or brain injury can be related to cause of death. Neuropathology should not be confused with neuropathy, which refers to disorders of the nerves themselves rather than the tissues. In neuropathology, the branches of the specializations of nervous system as well as the tissues come together into one field of study.

David A. Snowdon, is an epidemiologist and professor of neurology, formerly at the Sanders-Brown Center on Aging at the University of Kentucky. His research interests include antioxidants and aging, and the neuropathology of Alzheimer's disease, especially predictive factors in early life and the role of brain infarction.

<span class="mw-page-title-main">Amyloid plaques</span> Extracellular deposits of the amyloid beta protein

Amyloid plaques are extracellular deposits of the amyloid beta (Aβ) protein mainly in the grey matter of the brain. Degenerative neuronal elements and an abundance of microglia and astrocytes can be associated with amyloid plaques. Some plaques occur in the brain as a result of aging, but large numbers of plaques and neurofibrillary tangles are characteristic features of Alzheimer's disease. Abnormal neurites in amyloid plaques are tortuous, often swollen axons and dendrites. The neurites contain a variety of organelles and cellular debris, and many of them include characteristic paired helical filaments, the ultrastructural component of neurofibrillary tangles. The plaques are highly variable in shape and size; in tissue sections immunostained for Aβ, they comprise a log-normal size distribution curve with an average plaque area of 400-450 square micrometers (µm²). The smallest plaques, which often consist of diffuse deposits of Aβ, are particularly numerous. The apparent size of plaques is influenced by the type of stain used to detect them, and by the plane through which they are sectioned for analysis under the microscope. Plaques form when Aβ misfolds and aggregates into oligomers and longer polymers, the latter of which are characteristic of amyloid. Misfolded and aggregated Aβ is thought to be neurotoxic, especially in its oligomeric state.

Semantic dementia (SD), also known as semantic variant primary progressive aphasia (svPPA), is a progressive neurodegenerative disorder characterized by loss of semantic memory in both the verbal and non-verbal domains. However, the most common presenting symptoms are in the verbal domain. Semantic dementia is a disorder of semantic memory that causes patients to lose the ability to match words or images to their meanings. However, it is fairly rare for patients with semantic dementia to develop category specific impairments, though there have been documented cases of it occurring. Typically, a more generalized semantic impairment results from dimmed semantic representations in the brain.

<span class="mw-page-title-main">Neurofibrillary tangle</span> Aggregates of tau protein known as a biomarker of Alzheimers disease

Neurofibrillary tangles (NFTs) are aggregates of hyperphosphorylated tau protein that are most commonly known as a primary biomarker of Alzheimer's disease. Their presence is also found in numerous other diseases known as tauopathies. Little is known about their exact relationship to the different pathologies.

<span class="mw-page-title-main">Tauopathy</span> Medical condition

Tauopathy belongs to a class of neurodegenerative diseases involving the aggregation of tau protein into neurofibrillary or gliofibrillary tangles in the human brain. Tangles are formed by hyperphosphorylation of the microtubule protein known as tau, causing the protein to dissociate from microtubules and form insoluble aggregates. The mechanism of tangle formation is not well understood, and whether tangles are a primary cause of Alzheimer's disease or play a peripheral role is unknown.

Cognitive reserve is the mind's and brain's resistance to damage of the brain. The mind's resilience is evaluated behaviorally, whereas the neuropathological damage is evaluated histologically, although damage may be estimated using blood-based markers and imaging methods. There are two models that can be used when exploring the concept of "reserve": brain reserve and cognitive reserve. These terms, albeit often used interchangeably in the literature, provide a useful way of discussing the models. Using a computer analogy, brain reserve can be seen as hardware and cognitive reserve as software. All these factors are currently believed to contribute to global reserve. Cognitive reserve is commonly used to refer to both brain and cognitive reserves in the literature.

<span class="mw-page-title-main">Chronic traumatic encephalopathy</span> Neurodegenerative disease caused by head injury

Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease linked to repeated trauma to the head. The encephalopathy symptoms can include behavioral problems, mood problems, and problems with thinking. The disease often gets worse over time and can result in dementia.

Alzheimer's Disease Neuroimaging Initiative (ADNI) is a multisite study that aims to improve clinical trials for the prevention and treatment of Alzheimer's disease (AD). This cooperative study combines expertise and funding from the private and public sector to study subjects with AD, as well as those who may develop AD and controls with no signs of cognitive impairment. Researchers at 63 sites in the US and Canada track the progression of AD in the human brain with neuroimaging, biochemical, and genetic biological markers. This knowledge helps to find better clinical trials for the prevention and treatment of AD. ADNI has made a global impact, firstly by developing a set of standardized protocols to allow the comparison of results from multiple centers, and secondly by its data-sharing policy which makes available all at the data without embargo to qualified researchers worldwide. To date, over 1000 scientific publications have used ADNI data. A number of other initiatives related to AD and other diseases have been designed and implemented using ADNI as a model. ADNI has been running since 2004 and is currently funded until 2021.

<span class="mw-page-title-main">Oskar Fischer</span> Czech scientist (1876–1942)

Oskar Fischer was a Czech academic, psychiatrist and neuropathologist whose studies on dementia and Alzheimer disease were rediscovered in 2008.

Florbetaben, a fluorine-18 (18F)-labeled stilbene derivative, trade name NeuraCeq, is a diagnostic radiotracer developed for routine clinical application to visualize β-amyloid plaques in the brain. It is indicated for Positron Emission Tomography (PET) imaging of β-amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease (AD) and other causes of cognitive impairment. β-amyloid is a key neuropathological hallmark of AD, so markers of β-amyloid plaque accumulation in the brain are useful in distinguishing AD from other causes of dementia. The tracer successfully completed a global multicenter phase 0–III development program and obtained approval in Europe, US and South Korea in 2014.

Primary age-related tauopathy (PART) is a neuropathological designation introduced in 2014 to describe the neurofibrillary tangles (NFT) that are commonly observed in the brains of normally aged and cognitively impaired individuals that can occur independently of the amyloid plaques of Alzheimer's disease (AD). The term and diagnostic criteria for PART were developed by a large group of neuropathologists, spearheaded by Drs. John F. Crary and Peter T. Nelson. Despite some controversy, the term PART has been widely adopted, with the consensus criteria cited over 1130 times as of April 2023 according to Google Scholar.

Visual selective attention is a brain function that controls the processing of retinal input based on whether it is relevant or important. It selects particular representations to enter perceptual awareness and therefore guide behaviour. Through this process, less relevant information is suppressed.

The Rush Alzheimer's Disease Center (RADC) is a research center located in Rush University Medical Center. The Rush Alzheimer's Disease Center is one of 29 Alzheimer's centers in the U.S. designated and funded by the National Institute on Aging.

<span class="mw-page-title-main">Limbic-predominant age-related TDP-43 encephalopathy</span> (LATE) -- a form of dementia

LATE is a term that describes a prevalent condition with impaired memory and thinking in advanced age, often culminating in the dementia clinical syndrome. In other words, the symptoms of LATE are similar to those of Alzheimer's disease. 

Familial Danish Dementia is an extremely rare, neurodegenerative disease characterized by progressive cataracts, loss of hearing, cerebellar ataxia, paranoid psychosis, and dementia. Neuropathological hallmarks include extensive atrophy of all areas of the brain, chronic diffuse encephalopathy, and the presence of exceedingly thin and nearly totally demyelinated cranial nerves.

Martha Clare Morris was an American nutritional epidemiologist who studied the link between diet and Alzheimer's disease. She led a team of researchers at the Rush University Medical Center to develop the MIND diet.

References

  1. 1 2 3 Snowdon, David A. (2002). Aging with Grace: What the Nun Study Teaches Us About Leading Longer, Healthier, and More Meaningful Lives. New York, New York: Bantam Books. ISBN   0-553-38092-3.
  2. 1 2 3 4 5 Moore, Bernardine A. (1995). "Study of Nuns Turns up Clues to Brain Aging and Alzheimer's Disease". Public Health Reports. 110 (4): 508. ISSN   0033-3549. JSTOR   4597883.
  3. ↑ Dunkel, Tom (18 June 2006). "Offering an education in aging". Baltimore Sun. Retrieved 24 June 2023.
  4. ↑ "Nun Study to return to the University". The Minnesota Daily. 23 February 2009.
  5. ↑ Elizabeth Eisenstadt Evans (12 July 2021). "20 years later, lessons on aging from the 'Nun Study' resonate today". Global Sisters Report. Retrieved 19 May 2022.
  6. ↑ https://katoactonalz.org/
  7. ↑ "Margaret E Flanagan". Scholars @ UT Health San Antonio (in Spanish). Retrieved 2023-06-24.
  8. 1 2 3 4 Danner, DD; Snowdon, DA; Friesen, WV (2001). "Positive emotions in early life and longevity: findings from the nun study" (PDF). Journal of Personality and Social Psychology. 80 (5): 804–13. doi:10.1037/0022-3514.80.5.804. ISSN   0022-3514. PMID   11374751.
  9. 1 2 3 Iacono, D; Markesbery, W R.; Gross, M; Pletnikova, O; Rudow, G; Zandi, P; Troncoso, J C. (1 September 2009). "The Nun Study". Neurology. 73 (9): 665–673. doi:10.1212/WNL.0b013e3181b01077. PMC   2734290 . PMID   19587326.
  10. 1 2 Sirts, Kairit; Piguet, Olivier; Johnson, Mark (1 June 2017). "Idea density for predicting Alzheimer's disease from transcribed speech". arXiv: 1706.04473 .{{cite journal}}: Cite journal requires |journal= (help)
  11. ↑ Bennett, David A.; Schneider, Julie A.; Wilson, Zoe Arvanitakis and Robert S.; Wilson, RS (30 June 2012). "Overview and Findings from the Religious Orders Study". Current Alzheimer Research. 9 (6): 628–645. doi:10.2174/156720512801322573. PMC   3409291 . PMID   22471860.
  12. ↑ Snowdon, David A.; Kemper, Susan J.; Mortimer, James A.; Greiner, Lydia H.; Wekstein, David R.; Markesbery, William R. (21 February 1996). "Linguistic Ability in Early Life and Cognitive Function and Alzheimer's Disease in Late Life: Findings From the Nun Study". JAMA. 275 (7): 528–532. doi:10.1001/jama.1996.03530310034029. PMID   8606473. S2CID   13613023.
  13. 1 2 3 Patzwald, Gari-Anne; Wildt, Sister (2004-01-01). "The Use of Convent Archival Records in Medical Research: The School Sisters of Notre Dame Archives and the Nun Study". The American Archivist. 67 (1): 86–106. doi:10.17723/aarc.67.1.d558520196w85573. ISSN   0360-9081. PMID   15222313.
  14. ↑ "Neuropathology | Careers in Medicine". careersinmedicine.aamc.org. Retrieved 2023-06-24.
  15. ↑ "Neuropathology". UPMC | Life Changing Medicine. Retrieved 2023-06-24.
  16. ↑ Sauer, Alissa (9 January 2017). "What Nuns Are Teaching Us About Alzheimer's". Alzheimers.net.
  17. ↑ Snowdon, David A. (2 September 2003). "Healthy Aging and Dementia: Findings from the Nun Study". Annals of Internal Medicine. 139 (5_Part_2): 450–4. doi:10.7326/0003-4819-139-5_Part_2-200309021-00014. PMID   12965975. S2CID   207535774.
  18. ↑ "Neuropathology", Wikipedia, 2022-11-17, retrieved 2023-06-24
  19. ↑ Tyas, Suzanne L.; Snowdon, David A.; Desrosiers, Mark F.; Riley, Kathryn P.; Markesbery, William R. (November 2007). "Healthy ageing in the Nun Study: definition and neuropathologic correlates". Age and Ageing. 36 (6): 650–655. doi:10.1093/ageing/afm120. ISSN   1468-2834. PMC   2243258 . PMID   17906306.
  20. ↑ Schmitt, F.; Thomason, P. (2010-07-06). "William R. Markesbery, MD (1932-2010)". Neurology. 75 (1): 20. doi:10.1212/WNL.0b013e3181e73343. ISSN   0028-3878. S2CID   72347024.
  21. 1 2 3 Riley, Kathryn P.; Snowdon, David A.; Desrosiers, Mark F.; Markesbery, William R. (March 2005). "Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study". Neurobiology of Aging. 26 (3): 341–347. doi:10.1016/j.neurobiolaging.2004.06.019. PMID   15639312. S2CID   41770951.
  22. ↑ "Physical exercise and dementia". UK Alzheimer's Society. 2021. Retrieved 21 January 2021.
  23. ↑ Snowdon, David. Aging with Grace.
  24. ↑ Snowdon, David. Aging with Grace. pp. 121–123.
  25. ↑ Snowdon, David. Aging with Grace. p. 124.
  26. ↑ Montine, Thomas J.; Phelps, Creighton H.; Beach, Thomas G.; Bigio, Eileen H.; Cairns, Nigel J.; Dickson, Dennis W.; Duyckaerts, Charles; Frosch, Matthew P.; Masliah, Eliezer; Mirra, Suzanne S.; Nelson, Peter T.; Schneider, Julie A.; Thal, Dietmar Rudolf; Trojanowski, John Q.; Vinters, Harry V. (January 2012). "National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach". Acta Neuropathologica. 123 (1): 1–11. doi:10.1007/s00401-011-0910-3. ISSN   0001-6322. PMC   3268003 . PMID   22101365.
  27. ↑ Hyman, Bradley T.; Phelps, Creighton H.; Beach, Thomas G.; Bigio, Eileen H.; Cairns, Nigel J.; Carrillo, Maria C.; Dickson, Dennis W.; Duyckaerts, Charles; Frosch, Matthew P.; Masliah, Eliezer; Mirra, Suzanne S.; Nelson, Peter T.; Schneider, Julie A.; Thal, Dietmar Rudolf; Thies, Bill (January 2012). "National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease". Alzheimer's & Dementia. 8 (1): 1–13. doi:10.1016/j.jalz.2011.10.007. ISSN   1552-5260. PMC   3266529 . PMID   22265587.
  28. ↑ Snowdon, David (1997). "Aging and Alzheimer's Disease: Lessons from the Nun Study" (PDF). The Gerontologist. 37 (2): 150–6. doi: 10.1093/geront/37.2.150 . PMID   9127971.
  29. ↑ "FAQ". The Nun Study. The University of Minnesota. 15 December 208. Archived from the original on 12 May 2010.
  30. ↑ "Nun Study". School Sisters of Notre Dame.
  31. ↑ Gosche, K. M.; Mortimer, J. A.; Smith, C. D.; Markesbery, W. R.; Snowdon, D. A. (28 May 2002). "Hippocampal volume as an index of Alzheimer neuropathology: Findings from the Nun Study". Neurology. 58 (10): 1476–1482. CiteSeerX   10.1.1.631.4067 . doi:10.1212/WNL.58.10.1476. PMID   12034782. S2CID   24979186.
  32. ↑ Stein, Pamela Sparks; Desrosiers, Mark; Donegan, Sara Jean; Yepes, Juan F.; Kryscio, Richard J. (1 October 2007). "Tooth loss, dementia and neuropathology in the Nun Study". The Journal of the American Dental Association. 138 (10): 1314–1322. doi:10.14219/jada.archive.2007.0046. PMID   17908844.
  33. ↑ Keohane, Kieran; Balfe, Myles (July 2019). "The Nun Study and Alzheimer's disease: Quality of vocation as a potential protective factor?". Dementia. 18 (5): 1651–1662. doi:10.1177/1471301217725186. ISSN   1471-3012. PMID   28840756. S2CID   7553127.
  34. ↑ Keohane, Kieran; Balfe, Myles (2017-08-25). "The Nun Study and Alzheimer's disease: Quality of vocation as a potential protective factor?". Dementia. 18 (5): 1651–1662. doi:10.1177/1471301217725186. ISSN   1471-3012. PMID   28840756. S2CID   7553127.
  35. ↑ Weinstein, Netta; Legate, Nicole; Ryan, William S.; Hemmy, Laura (2019). "Autonomous orientation predicts longevity: New findings from the Nun Study". Journal of Personality. 87 (2): 181–193. doi:10.1111/jopy.12379. ISSN   1467-6494. PMC   6446812 . PMID   29524338.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.